Interestingly, treatment with the hsa-miR-AMC1 antagomir significantly inhibited infection of pancreatic β cells (p <0.0001) by either the prototype CVB4-JVB strain (Figure 2A) or the diabetogenic CVB4-E2 variant (Figure 2B). Here, LGI4 is linked to infection.